UB-421

anti-CD4 antibody

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for UB-421, covering 2014-08-20 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection [Phase 2]

See pricing